Literature DB >> 16831497

Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene.

Emmie de Wit1, Monique I J Spronken, Guus F Rimmelzwaan, Albert D M E Osterhaus, Ron A M Fouchier.   

Abstract

The incorporation of the eight gene segments of influenza A virus in virions, either through a random or a specific mechanism, has been under debate for many years. Using reverse genetics techniques and trans-complementation of viral proteins, we showed that the production of viruses containing seven gene segments is very inefficient, which can be overcome by providing the 8th gene segment in a non-functional form. We conclude that sequences in the 5' and 3' ends of the polymerase gene segments contain packaging signals. Our methods will facilitate the further mapping of the packaging signals of influenza A virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831497     DOI: 10.1016/j.vaccine.2006.06.001

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication.

Authors:  Makoto Ozawa; Junko Maeda; Kiyoko Iwatsuki-Horimoto; Shinji Watanabe; Hideo Goto; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

2.  Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus.

Authors:  Edward C Hutchinson; Martin D Curran; Eliot K Read; Julia R Gog; Paul Digard
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

3.  Influenza A viruses with different amino acid residues at PB2-627 display distinct replication properties in vitro and in vivo: revealing the sequence plasticity of PB2-627 position.

Authors:  Alex W H Chin; Olive T W Li; Chris K P Mok; Miko K W Ng; Malik Peiris; Leo L M Poon
Journal:  Virology       Date:  2014-09-28       Impact factor: 3.616

Review 4.  Structure of influenza virus ribonucleoprotein complexes and their packaging into virions.

Authors:  Takeshi Noda; Yoshihiro Kawaoka
Journal:  Rev Med Virol       Date:  2010-11       Impact factor: 6.989

5.  Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences.

Authors:  Ken Fujii; Makoto Ozawa; Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2009-03-18       Impact factor: 3.891

6.  Limited compatibility between the RNA polymerase components of influenza virus type A and B.

Authors:  Kiyoko Iwatsuki-Horimoto; Yasuko Hatta; Masato Hatta; Yukiko Muramoto; Hualan Chen; Yoshihiro Kawaoka; Taisuke Horimoto
Journal:  Virus Res       Date:  2008-05-02       Impact factor: 3.303

7.  Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection.

Authors:  Maria Joao Amorim; Richard Y Kao; Paul Digard
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

8.  Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus.

Authors:  Takeshi Noda; Yukihiko Sugita; Kazuhiro Aoyama; Ai Hirase; Eiryo Kawakami; Atsuo Miyazawa; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  Nat Commun       Date:  2012-01-24       Impact factor: 14.919

9.  Codon conservation in the influenza A virus genome defines RNA packaging signals.

Authors:  Julia R Gog; Emmanuel Dos Santos Afonso; Rosa M Dalton; India Leclercq; Laurence Tiley; Debra Elton; Johann C von Kirchbach; Nadia Naffakh; Nicolas Escriou; Paul Digard
Journal:  Nucleic Acids Res       Date:  2007-03-01       Impact factor: 16.971

10.  Optimisations and Challenges Involved in the Creation of Various Bioluminescent and Fluorescent Influenza A Virus Strains for In Vitro and In Vivo Applications.

Authors:  Monique I Spronken; Kirsty R Short; Sander Herfst; Theo M Bestebroer; Vincent P Vaes; Barbara van der Hoeven; Abraham J Koster; Gert-Jan Kremers; Dana P Scott; Alexander P Gultyaev; Erin M Sorell; Miranda de Graaf; Montserrat Bárcena; Guus F Rimmelzwaan; Ron A Fouchier
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.